AGP Executive Report
Last update: 4 hours agoEbola Response: Cases are declining in parts of the DRC, but new hotspots and cross-border spread remain a concern. By Oct. 6, the Bundibugyo outbreak had caused 4,205 deaths among 8,728 confirmed cases. Vaccine Research: Oxford’s candidate vaccine has entered Phase Ib trials in Uganda, with a Moderna candidate also cleared to begin. No vaccine is specifically approved for Bundibugyo Ebola. Mineral Mapping: The DRC has launched a three-year airborne survey using seven aircraft to map mineral potential across nine provinces and expand geological coverage, aiming to attract investment and strengthen state oversight of resource data. AI Exploration: KoBold Metals is using AI to analyze soil samples, satellite imagery and colonial-era drill records to identify promising lithium sites in the DRC.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
